AAAAAA
Results:
1-8
|
Results: 8
Authors:
Kloner, RA
Weinberger, M
Pool, JL
Chrysant, SG
Prasad, R
Harris, SM
Zyczynski, TM
Leidy, NK
Michelson, EL
Citation: Ra. Kloner et al., Comparative effects of candesartan cilexetil and amlodipine inpatients with mild systemic hypertension, AM J CARD, 87(6), 2001, pp. 727-731
Authors:
Pool, JL
Citation: Jl. Pool, The role of angiotensin II in hypertension and end-organ damage, INT J CL PR, 2000, pp. 4-8
Authors:
Kirby, RS
Pool, JL
Citation: Rs. Kirby et Jl. Pool, Interpretation of the ALLHAT interim analysis and implications for the treatment of patients with BPH, PROSTATE C, 3(3), 2000, pp. 152-156
Authors:
Pool, JL
Citation: Jl. Pool, Neurosurgical notes: World War II, NEUROSURGER, 46(3), 2000, pp. 721-728
Authors:
Pool, JL
Glazer, R
Chiang, YT
Gatlin, M
Citation: Jl. Pool et al., Dose-response efficacy of valsartan, a new angiotensin II receptor blocker, J HUM HYPER, 13(4), 1999, pp. 275-281
Authors:
Taylor, AA
Shepherd, AM
Polvino, W
Mangoo-Karim, R
Ballard, K
Sunthornyothin, S
Luther, RR
Pool, JL
Citation: Aa. Taylor et al., Prolonged fenoldopam infusions in patients with mild to moderate hypertension - Pharmacodynamic and pharmacokinetic effects, AM J HYPERT, 12(9), 1999, pp. 906-914
Authors:
Taylor, AA
Mangoo-Karim, R
Ballard, KD
Luther, RR
Pool, JL
Citation: Aa. Taylor et al., Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: A dose-tolerabilitystudy, J CLIN PHAR, 39(5), 1999, pp. 471-479
Authors:
Jenkins, CD
Miller, TQ
Hewitt, LO
Wallace, JM
Pool, JL
Citation: Cd. Jenkins et al., A 3-dimensional analysis of modes of cardiovascular adaptation: concepts, methods and preliminary findings, CLIN INV M, 21(6), 1998, pp. 228-250
Risultati:
1-8
|